Clinical Study

Treatment For Acute Hepatitis C Infection

Posted Date: Oct 26, 2021

  • Investigator: Kenneth Sherman
  • Specialties:
  • Type of Study: Drug

the safety and success (efficacy) of treating people with acute hepatitis C with oral medications Glecaprevir/Pibrentasvir (Mavyret) for 8 weeks

Criteria:

Adult Weighing At Least 45Kg (99Lbs), Must Have Evidence Of Acute Hepatitis C (Hcv) Infection By Lab Reports Or Clinical Signs And Symptoms Within A Certain Time Period, Able To Take Pills, Will Attend All Study Visits.

Keywords:

Hcv

For More Information:

Elizabeth Stambrook
513-584-2363
liz.stambrook@uchealth.com